Obagi C-Therapy Night Cream
Texto original en francés.
Producto de salud natural autorizado en Canadá
- Titular
- Obagi Medical Products, a division of Valeant Pharmaceuticals North America LLC.
- NPN o DIN-HM
- 80040470
- Estado
- Licencia no activa
- Fecha de licencia
- 28 de febrero de 2013
- Fecha de revisión
- 7 de marzo de 2014
- Forma
- Crème
- Vía de administración
- Topique
- Tipo de solicitud
- Non traditionnelle
El análisis de dosis orales no se aplica sin una vía exclusivamente oral establecida.
Composición
| Ingrediente medicinal y fuente | Por unidad posológica, según la fuente |
|---|---|
| 1,4-Benzènediol Fuente : Hydroquinone | 4,16 % |
Ingredientes no medicinales
Parahydroxybenzoate de méthyle, Saponins, Alcool cétylique, Phényl triméthicone, Métabisulfite de sodium, (p)-hydroxybenzoate de propyle, Glycérine, Eau purifiée, Acétate de dl-alpha tocophéryle, PPG-2-Myristyl Ether Propionate, Edetate Disodium, Vitamine C, BHT, Laureth sulfate de sodium
Dosis recomendadas en Canadá
| Población | Edad | Cantidad por toma | Frecuencia |
|---|---|---|---|
| Adultes | Non précisée | Non précisée | Non précisée |
Usos autorizados en Canadá
For the gradual lightening of hyperpigmented skin conditions.
Texto original en inglés.
Un uso autorizado en Canadá no es una declaración de propiedades saludables autorizada en la Unión Europea. Consulte el registro de declaraciones de propiedades saludables.
Advertencias en Canadá
Contra-Indications : People with prior history of sensitivity or allergic reactions to this product or any of its ingredients should not use the products. If you have a family history of, have or have had, or are at risk of developing cancer, do not use. The safety of topical hydroquinone use during pregnancy or in children (12 years and under) has not been established. Not for use on children under 12 years of age. Do not use this product if you are nursing, pregnant or if you intend to become pregnant within three months of use.
Texto original en inglés.
Known Adverse Reactions : No systemic adverse reactions have been reported. Discontinue use in case of irritation, rash, excessive inflammatory response or if a gradual blue-black darkening of the skin (exogenous ochronosis) occurs. Minor redness is acceptable, but where there is excessive irritation, a rash or other reaction, further treatment is not advised. Severe itching or reddening may occur, in which the product should be discontinued and the physician notified immediately. Contains sodium metabisulfate, a sulfate that may cause serious allergic type reactions (e.g., hives, itching, wheezing, anaphylaxis, severe asthma attacks) in certain susceptible persons.
Texto original en inglés.
Cautions and Warnings : To be used only on the advice of a physician. Use only as directed. Apply only to small skin surface areas. Do not apply over sunburn or irritated skin. A mild transient stinging or minor redness may occur in people with sensitive skin. Discontinue use and consult a physician in case of skin reactions or a blue-black darkening of the skin. Hydroquinone is a skin bleaching agent which may produce unwanted cosmetic effects if not used as directed. Treatment should be limited to relatively small areas of the body at one time. Sunscreen use is an essential aspect of hydroquinone therapy because even minimal sunlight exposure may cause skin re-darkening. Limit sun exposure and apply a sunburn protectant while using this product and for a week afterwards. For external use only. Do not use near eyes, mucous membranes, or on broken or irritated skin. In case of contact, rinse thoroughly with water. In case of accidental ingestion, seek medical assistance or contact a Poison Control Center immediately. A bitter taste and anesthetic effect may occur if applied to lips. Test for skin sensitivity. To test for sensitivity apply to an area of approximately 1 cm2 of unbroken skin on the inside of the arm. If no irritation occurs within 24 hours, begin treatment for up to 12 weeks. Keep out of reach of children. Note: slight darkening of the product is normal and does not affect its potency. The physician should be familiar with the contents of this insert before prescribing of dispensing this product. Close patient supervision is recommended.
Texto original en inglés.
Fuente
Ficha oficial de Health Canada, licencia 80040470
Base de datos de productos de salud natural autorizados (BDPSNH), Health Canada: productos autorizados, ingredientes, dosis, usos y advertencias, consultado el 27 de octubre de 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Texto original en inglés.
Texto original en francés.
La fórmula vendida en Europa con el mismo nombre puede ser diferente. Esta información no sustituye el consejo de un médico o farmacéutico.
Lista en la revisión oficial del (registro: Base de datos de productos de salud natural autorizados (BDPSNH), Health Canada: productos autorizados, ingredientes, dosis, usos y advertencias).
¿Alguna información inexacta o más reciente sobre este producto, sea usted lector o marca? Escriba a contact@compoatlas.com: cada corrección se publica en el registro de correcciones.